abstract |
The application provides methods for treatment or prophylaxis of dengue virus mediated diseases with compounds of Formula I n n n n n n n n n n wherein R 1 , R 2a , R 2b , R 3 , R 4 , R 5 R 6 , R 8a , R 9 and R 10 are as defined herein. The application further discloses methods for treatment or prophylaxis of dengue virus mediated diseases with pharmaceutical compositions comprising compounds of Formula I. |